Earnings · China A-shares
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Class A (603456) earnings
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-21: net profit -17.50% year on year, -17.54% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -4.35% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-21
- Period end
- 2026-09-30
- Net profit YoY
- -17.50%
- Excl. one-offs YoY
- -17.54%
- Net profit QoQ
- +6.54%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -4.11% | — |
| 3 days | -4.35% | — |
| 7 days | -7.86% | — |
| 14 days | -2.44% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 3 of 7 reports (average -1.85%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-22 | ¥616.78M | -17.50% | -17.54% | -5.38% | 0.69 | 6.92% | -4.35% | — | — |
| 2026 interim report | 2026-08-04 | ¥387.39M | -26.33% | -26.56% | -10.30% | 0.44 | 4.35% | +2.99% | +2.59% | +3.63% |
| 2026 Q1 report | 2026-04-24 | ¥172.08M | -31.22% | -32.67% | -19.43% | 0.19 | 1.95% | -14.45% | -25.33% | -25.75% |
| 2025 annual report | 2026-04-24 | ¥730.07M | +20.46% | +22.83% | +6.74% | 0.82 | 8.47% | -14.45% | -25.33% | -25.75% |
| 2025 Q3 report | 2025-10-16 | ¥747.65M | +18.51% | +20.67% | +4.92% | 0.84 | 8.57% | -9.12% | -9.17% | -7.23% |
| 2025 interim report | 2025-08-06 | ¥525.83M | +10.70% | +12.40% | +3.86% | 0.59 | 6.02% | -2.63% | +8.57% | -1.85% |
| 2025 Q1 report | 2025-04-15 | ¥250.20M | +5.68% | +7.17% | +0.98% | 0.28 | 2.89% | +4.55% | +18.51% | +15.50% |
| 2024 annual report | 2025-04-11 | ¥606.10M | -41.34% | -42.06% | -6.57% | 0.68 | 7.18% | +10.04% | +17.10% | +13.72% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.